SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-059550
Filing Date
2024-05-14
Accepted
2024-05-14 16:11:03
Documents
54
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q maia-20240331.htm   iXBRL 10-Q 1231109
2 EX-4.1 maia-ex4_1.htm EX-4.1 29748
3 EX-4.2 maia-ex4_2.htm EX-4.2 29757
4 EX-4.3 maia-ex4_3.htm EX-4.3 29721
5 EX-31.1 maia-ex31_1.htm EX-31.1 16781
6 EX-31.2 maia-ex31_2.htm EX-31.2 17336
7 EX-32.1 maia-ex32_1.htm EX-32.1 9559
8 EX-32.2 maia-ex32_2.htm EX-32.2 10740
  Complete submission text file 0000950170-24-059550.txt   5988548

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT maia-20240331.xsd EX-101.SCH 983336
57 EXTRACTED XBRL INSTANCE DOCUMENT maia-20240331_htm.xml XML 858276
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 24944444
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)